IL108467A - Modified oligodeoxyribo-nucleotides their preparation and their therapeutic use - Google Patents

Modified oligodeoxyribo-nucleotides their preparation and their therapeutic use

Info

Publication number
IL108467A
IL108467A IL10846794A IL10846794A IL108467A IL 108467 A IL108467 A IL 108467A IL 10846794 A IL10846794 A IL 10846794A IL 10846794 A IL10846794 A IL 10846794A IL 108467 A IL108467 A IL 108467A
Authority
IL
Israel
Prior art keywords
group
ete
dbp
meoph
mee
Prior art date
Application number
IL10846794A
Other languages
English (en)
Other versions
IL108467A0 (en
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL108467A0 publication Critical patent/IL108467A0/xx
Publication of IL108467A publication Critical patent/IL108467A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/336—Modified G
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL10846794A 1993-01-29 1994-01-28 Modified oligodeoxyribo-nucleotides their preparation and their therapeutic use IL108467A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1350993 1993-01-29
JP13557393 1993-06-07
JP13851793 1993-06-10

Publications (2)

Publication Number Publication Date
IL108467A0 IL108467A0 (en) 1994-04-12
IL108467A true IL108467A (en) 1999-09-22

Family

ID=27280283

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10846794A IL108467A (en) 1993-01-29 1994-01-28 Modified oligodeoxyribo-nucleotides their preparation and their therapeutic use

Country Status (19)

Country Link
US (2) US5674856A (da)
EP (1) EP0611075B1 (da)
KR (1) KR100318796B1 (da)
CN (2) CN1039014C (da)
AT (1) ATE146479T1 (da)
AU (1) AU670154B2 (da)
CA (1) CA2114355A1 (da)
CZ (1) CZ287050B6 (da)
DE (1) DE69401136T2 (da)
DK (1) DK0611075T3 (da)
ES (1) ES2098866T3 (da)
FI (1) FI111265B (da)
GR (1) GR3022821T3 (da)
HK (1) HK1000191A1 (da)
HU (1) HU222834B1 (da)
IL (1) IL108467A (da)
NO (1) NO309427B1 (da)
NZ (2) NZ250795A (da)
RU (1) RU2111971C1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2114355A1 (en) * 1993-01-29 1994-07-30 Hidehiko Furukawa Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
US6291438B1 (en) 1993-02-24 2001-09-18 Jui H. Wang Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
CN1060177C (zh) * 1997-06-28 2001-01-03 中国科学院上海生物化学研究所 3′－单磷酸化寡核苷酸
GB9823646D0 (en) 1997-12-19 1998-12-23 Brax Genomics Ltd Compounds for mass spectrometry
US6995259B1 (en) * 1998-10-23 2006-02-07 Sirna Therapeutics, Inc. Method for the chemical synthesis of oligonucleotides
DE10041809A1 (de) * 2000-08-25 2002-03-07 Giesing Michael Arrays immobilisierter Biomoleküle, deren Herstellung und Verwendung
US7205399B1 (en) 2001-07-06 2007-04-17 Sirna Therapeutics, Inc. Methods and reagents for oligonucleotide synthesis
US9394167B2 (en) 2005-04-15 2016-07-19 Customarray, Inc. Neutralization and containment of redox species produced by circumferential electrodes
US20070065877A1 (en) * 2005-09-19 2007-03-22 Combimatrix Corporation Microarray having a base cleavable succinate linker
EP2511260B1 (en) * 2009-12-08 2015-07-29 Gifu University Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct
WO2011090793A2 (en) 2010-01-20 2011-07-28 Customarray, Inc. Multiplex microarray of serially deposited biomolecules on a microarray
CN102766183B (zh) * 2011-05-05 2016-09-14 中国人民解放军军事医学科学院毒物药物研究所 具有抗hiv-1融合活性的修饰的核酸结构
CN116496335B (zh) * 2023-03-21 2024-03-08 中国药科大学 一种修饰核苷酸及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU550148B2 (en) * 1980-02-29 1986-03-06 University Patents Inc. Supports for use in preparation of polynucleotides
US4849513A (en) * 1983-12-20 1989-07-18 California Institute Of Technology Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
FR2568254B1 (fr) * 1984-07-25 1988-04-29 Centre Nat Rech Scient Application d'oligonucleotides lies a un agent intercalant, notamment a titre de medicament
US5252760A (en) * 1985-03-28 1993-10-12 Chiron Corporation Method of using colored phosphorylating reagents
US4950745A (en) * 1986-10-30 1990-08-21 Daicel Chemical Industries, Ltd. Process for synthesis of oligonucleotides and compound for forming polymeric protecting group
DE3785343T2 (de) * 1986-12-02 1993-07-22 Centre Nat Rech Scient Alpha-oligonukleotide.
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
US4904582A (en) * 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
WO1990012022A1 (en) * 1989-03-31 1990-10-18 University Patents, Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
WO1992008729A1 (en) * 1990-11-20 1992-05-29 Sankyo Company, Limited Antisense nucleic acid derivative
US5672697A (en) * 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
US5220003A (en) * 1991-03-29 1993-06-15 The Regents Of The University Of California Process for the synthesis of 2',3'-dideoxynucleosides
JP3061659B2 (ja) * 1991-08-01 2000-07-10 ヤマサ醤油株式会社 ２−｛２−（モノメトキシトリチルオキシ）エチルチオ｝エチル基および該基の使用法
NZ245720A (en) * 1992-01-22 1995-12-21 Hoechst Ag Oligonucleotide analogues; use as gene expression inhibitor or dna probe
US5646261A (en) * 1992-01-22 1997-07-08 Hoechst Aktiengesellschaft 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
CA2114355A1 (en) * 1993-01-29 1994-07-30 Hidehiko Furukawa Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
JPH09208729A (ja) * 1996-02-02 1997-08-12 Sekisui Chem Co Ltd 帯電防止プラスチックプレートもしくはシートの製造方法

Also Published As

Publication number Publication date
CN1065238C (zh) 2001-05-02
KR940018394A (ko) 1994-08-16
RU2111971C1 (ru) 1998-05-27
HU9400246D0 (en) 1994-05-30
ES2098866T3 (es) 1997-05-01
CZ19094A3 (en) 1994-12-15
AU5473194A (en) 1994-08-04
EP0611075B1 (en) 1996-12-18
HU222834B1 (hu) 2003-11-28
US5807837A (en) 1998-09-15
EP0611075A1 (en) 1994-08-17
NZ280616A (en) 1997-04-24
NO940310L (no) 1994-08-01
HUT66266A (en) 1994-10-28
FI111265B (fi) 2003-06-30
AU670154B2 (en) 1996-07-04
US5674856A (en) 1997-10-07
DE69401136D1 (de) 1997-01-30
IL108467A0 (en) 1994-04-12
NO940310D0 (no) 1994-01-28
CN1039014C (zh) 1998-07-08
NZ250795A (en) 1997-04-24
HK1000191A1 (en) 1998-01-27
FI940425A7 (fi) 1994-11-04
CN1193013A (zh) 1998-09-16
FI940425A0 (fi) 1994-01-28
NO309427B1 (no) 2001-01-29
KR100318796B1 (ko) 2002-06-20
CA2114355A1 (en) 1994-07-30
ATE146479T1 (de) 1997-01-15
CZ287050B6 (en) 2000-08-16
CN1098107A (zh) 1995-02-01
DK0611075T3 (da) 1997-07-07
DE69401136T2 (de) 1997-07-10
GR3022821T3 (en) 1997-06-30
HK1016151A1 (en) 1999-10-29

Similar Documents

Publication Publication Date Title
KR100211552B1 (ko) 유전자 발현 억제용 화합물 및 방법
JP6038860B2 (ja) リン原子修飾核酸の合成方法
US8901289B2 (en) Preparation of nucleotide oligomer
JP7263236B2 (ja) 新規二環式ヌクレオシドおよびそれから調製されたオリゴマー
AU9063398A (en) Oligonucleotide analogues
MXPA96004355A (en) Oligonucleotides and used modified intermediaries in nucleic acids therapeuti
JPH09511250A (ja) 核酸治療に有用な修飾オリゴヌクレオチド及び中間体
MXPA00011473A (es) Nuevos nucleosidos que tienen una porcion de azucar biciclica.
AU716391B2 (en) Solid phase synthesis of oligonucleotides
EP0611075B1 (en) Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
JPH10195098A (ja) 新規ヌクレオチド類縁体
JPH0787982A (ja) 修飾オリゴデオキシリボヌクレオチド
WO1988004301A1 (fr) OLIGONUCLEOTIDES alpha
HK1000191B (en) Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
JP2000506849A (ja) オリゴヌクレオチド類似体
KR20230074205A (ko) 핵산 올리고머의 제조 방법
WO1990012022A1 (en) Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
EP1608669A1 (en) Silylated oligonucleotide compounds
WO2002018406A1 (en) Alkylated hexitol nucleoside analogues and oligomers thereof
CN120904263B (zh) 具有增加寡核苷酸体内稳定性的2'核糖修饰的核苷酸化合物及其合成方法与应用
JP7776154B2 (ja) ホスホロチオエート及びボラノホスフェートを含むキメラ型核酸オリゴマー、及びその製造方法
JPH069682A (ja) レトロウイルス感染用治療薬としてのポリヌクレオチドホスホロジチオエート
WO1998049183A1 (en) Base protecting groups and process for oligonucleotide synthesis
JPH0892275A (ja) 修飾オリゴデオキシリボヌクレオチド
JP2000505081A (ja) オリゴヌクレオチドｎ３’→ｐ５’ホスホルアミデートの固相合成

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees